Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma-Reference-Cited by-同舟云学术

Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma

Published:2021-05-08 Issue:6 Volume:62 Page:1325-1334
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Goyal Ravi K.¹^ORCID,Jain Preetesh²,Nagar Saurabh P.¹,Le Hannah³,Kabadi Shaum M.⁴,Davis Keith¹,Kaye James A.⁵,Du Xianglin L.⁶,Wang Michael²^ORCID

Affiliation:

1. Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA

2. Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA

3. US HEOR Oncology, AstraZeneca, Gaithersburg, MD, USA

4. Epidemiology and Real-World Evidence in Oncology, AstraZeneca, Gaithersburg, MD, USA

5. Department of Epidemiology, RTI Health Solutions, Waltham, MA, USA

6. The University of Texas Health Science Center at Houston, Houston, TX, USA

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1919662

Reference21 articles.

1. Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas

2. National Comprehensive Cancer Network (NCCN) [Internet]. Clinical practice guidelines in oncology: B-cell lymphomas. Version 1. 2017. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2020. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx

3. Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States

4. Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections in patients with mantle cell lymphoma;HemaSphere;2024-07

2. Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis;Clinical Lymphoma Myeloma and Leukemia;2024-06

3. Assessing unmet need among elderly Medicare Beneficiaries with Mantle cell lymphoma: an analysis of treatment patterns, survival, healthcare resource utilization, and costs;Leukemia & Lymphoma;2023-07-27

4. Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation;Blood Advances;2023-03-14

5. Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study;Advances in Hematology;2022-12-28